Lumedica was one of a handful of startups that were invited to give two-minute business pitches to a group of investors at NCBiotech’s Annual CED Conference. Lumedica, incubated at BioLabsNC, is currently selling its OCT products to the scientific market, but has its sights set on a larger, clinical market. President and Chief Scientist Adam Wax took investors through our patented, low-cost OCT technology and its potential market impact. “It’s always great to get in front of tech-savvy investors.” said Wax. “We know there’s a need for low-cost technologies like ours in the healthcare space. It’s an exciting time for Lumedica as we look for partners and investors to accelerate our path toward the clinical market.”